USD10
PROK Shares
About ProKidneyProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

USD10
PROK Shares
About ProKidneyProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

Stats

TRADING WINDOW

Closed

OPENS AT

Apr 8 at 1:30 PM GMT+0

MARKET CAP

$269.69M

OPEN PRICE

Not enough data

LOW (1Y)

$0.4603

HIGH (1Y)

$7.13

LOW (24H)

$1.73

HIGH (24H)

$1.95

VOLUME (24H)

$126.00

99.99%

Price history

Time
Price
Change
Today
Not enough data
Not enough data
1 Day
$1.83
3.83%
1 Week
$1.79
6.15%
1 Month
$2.20
13.64%
1 Year
$0.5825
226.18%
Past performance is not a reliable indicator of future results.

Discover more

Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.